RxDoctor Payments Data

Maggie Ziebold

Nurse Practitioner · Buffalo, NYNPI 1710426929

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 83.6% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $9,370 and has fallen 88.9% since, to $1,042 in 2025. Among nurse practitioner clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,132in general payments, 2019–2025

Across 84 payments — averaging $132.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$9K
  • Microtransponder, Inc.$735
  • Teva Pharmaceuticals USA, Inc.$452
  • AbbVie$110
  • Merz Pharmaceuticals, LLC$97
  • Neurocrine Biosciences, Inc.$95
  • plus $340 from 11 others

What the payments were for

  • Consulting fees$3503%
  • Speaking & faculty fees$5,62251%
  • Travel & lodging$3,11028%
  • Food & beverage$2,05018%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,132 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.

See all nurse practitioner providers in New York

Medicare billing

Part B allowed, 2024
$22,864
Medicare patients
132
Services billed
241

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban38$43,121
Atorvastatin Calcium66$1,163
Levetiracetam48$1,142
Rosuvastatin Calcium46$860
ClopidogrelClopidogrel Bisulfate53$762
Gabapentin13$278

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →